Get the latest tech news
Cradle builds out its protein-design AI platform (and wet lab) with $73M in new funding
Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and
The company’s founder and CEO, Stef van Grieken, memorably referred to the strings of amino acids and bases as “an alien programming language,” but one that an AI model can still parse to some extent. The company’s approach was to accelerate testing of large biomolecules like proteins (which serve countless purposes in medicine and industry) by attempting to find and recommend sequences that affect desirable qualities. “Companies developing products like antibody therapeutics against a certain disease or enzymes for a detergent will typically run dozens of experimental rounds to improve the efficacy, safety, and manufacturability of their protein,” he said in an email to TechCrunch.
Or read this on TechCrunch